Invention Grant
- Patent Title: Inhibitors of protein tyrosine kinase activity
- Patent Title (中): 抑制蛋白酪氨酸激酶活性
-
Application No.: US12920676Application Date: 2009-02-27
-
Publication No.: US08729268B2Publication Date: 2014-05-20
- Inventor: Michael Mannion , Stéphane Raeppel , Stephen William Claridge , Frédéric Gaudette , Lijie Zhan , Ljubomir Isakovic , Oscar Mario Saavedra , Tetsuyuki Uno , Masashi Kishida , Arkadii Vaisburg
- Applicant: Michael Mannion , Stéphane Raeppel , Stephen William Claridge , Frédéric Gaudette , Lijie Zhan , Ljubomir Isakovic , Oscar Mario Saavedra , Tetsuyuki Uno , Masashi Kishida , Arkadii Vaisburg
- Applicant Address: CA Montreal
- Assignee: MethylGene Inc.
- Current Assignee: MethylGene Inc.
- Current Assignee Address: CA Montreal
- Agency: Wood, Phillips, Katz, Clark & Mortimer
- International Application: PCT/CA2009/000228 WO 20090227
- International Announcement: WO2009/109035 WO 20090911
- Main IPC: A61K31/4365
- IPC: A61K31/4365 ; C07D513/04
Abstract:
This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions.
Public/Granted literature
- US20110098293A1 Inhibitors of Protein Tyrosine Kinase Activity Public/Granted day:2011-04-28
Information query
IPC分类:
